HC: Allows Natco and Alembic to export Bayer’s patented drugs ‘Sorafenib’ and ‘Rivaroxaban’ under Bolar provision
Mar 17, 2017
|
Simply Register/Sign In to access the free content across the portals!
Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals